avapro has been researched along with Renal Insufficiency in 5 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Associations between baseline proteinuria and proteinuria reduction by either irbesartan, amlodipine, or control for similar decrements in blood pressure and the cumulative incidence of renal end points were examined using the Kaplan-Meier method in patients enrolled in the Irbesartan Diabetic Nephropathy Trial." | 5.11 | Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. ( Atkins, RC; Braden, G; Briganti, EM; Champion de Crespigny, PJ; DeFerrari, G; Drury, P; Hunsicker, LG; Lewis, EJ; Lewis, JB; Locatelli, F; Wiegmann, TB, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, R | 1 |
| Suzuki, J | 1 |
| Wakayama, K | 1 |
| Kumagai, H | 1 |
| Ikeda, Y | 1 |
| Akazawa, H | 1 |
| Komuro, I | 1 |
| Isobe, M | 1 |
| Atkins, RC | 1 |
| Briganti, EM | 1 |
| Lewis, JB | 1 |
| Hunsicker, LG | 1 |
| Braden, G | 1 |
| Champion de Crespigny, PJ | 1 |
| DeFerrari, G | 1 |
| Drury, P | 1 |
| Locatelli, F | 1 |
| Wiegmann, TB | 1 |
| Lewis, EJ | 1 |
| Schwarzbeck, A | 1 |
| Wittenmeier, KW | 1 |
| Hällfritzsch, U | 1 |
| De Rosa, ML | 1 |
| de Cristofaro, A | 1 |
| Rossi, M | 1 |
| Baiano, A | 1 |
| Cardace, P | 1 |
| Albanese, L | 1 |
| Vigorito, C | 1 |
| Cao, Z | 1 |
| Cox, A | 1 |
| Bonnet, F | 1 |
2 trials available for avapro and Renal Insufficiency
| Article | Year |
|---|---|
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy.
Topics: Adult; Aged; Amlodipine; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nep | 2005 |
Irbesartan effects on renal function in patients with renal impairment and hypertension: a drug-withdrawal study.
Topics: Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Creatinine; Drug Administr | 2001 |
3 other studies available for avapro and Renal Insufficiency
| Article | Year |
|---|---|
Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Heart; Irbesartan; Male; Myoca | 2016 |
Anaemia in dialysis patients as a side-effect of sartanes.
Topics: Anemia; Antihypertensive Agents; Biphenyl Compounds; Hemoglobins; Humans; Irbesartan; Kidney Transpl | 1998 |
Increased osteopontin expression following renal ablation is attenuated by angiotensin type 1 receptor antagonism.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cell | 2002 |